Mitochondrial dysfunction and Alzheimer's disease

被引：99
|
作者：
Maruszak, Aleksandra [1 ]
Zekanowski, Cezary [1 ]
机构：
[1] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, PL-02106 Warsaw, Poland
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2011年 / 35卷 / 02期
关键词：
Alzheimer's disease; APOE4; Mitochondrial DNA (mtDNA); Mitochondrial dysfunction; Mitochondrial haplogroups; Oxidative stress; CYTOCHROME-C-OXIDASE; AMYLOID PRECURSOR PROTEIN; KETOGLUTARATE DEHYDROGENASE COMPLEX; OXIDATIVELY MODIFIED PROTEINS; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; OXYGEN SPECIES PRODUCTION; MATERNAL FAMILY-HISTORY; FREE-RADICAL GENERATION; MTDNA CONTROL-REGION;
D O I：
10.1016/j.pnpbp.2010.07.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
To date, one of the most discussed hypotheses for Alzheimer's disease (AD) etiology implicates mitochondrial dysfunction and oxidative stress as one of the primary events in the course of AD. In this review we focus on the role of mitochondria and mitochondrial DNA (mtDNA) variation in AD and discuss the rationale for the involvement of mitochondrial abnormalities in AD pathology. We summarize the current data regarding the proteins involved in mitochondrial function and pathology observed in AD, and discuss the role of somatic mutations and mitochondrial haplogroups in AD development. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：320 / 330
页数：11
相关论文
共 50 条
  • [21] Mitochondrial dysfunction and neuronal apoptosis in Alzheimer's disease
    Takuma, Kazuhiro
    Fukuzaki, Emiko
    Nagai, Taku
    Mizoguchi, Hiroyuki
    Stern, David M.
    Yan, Shirley ShiDu
    Yamada, Kiyofumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 45P - 45P
  • [22] Mitochondrial dysfunction and mitophagy failure in Alzheimer's disease
    Mary, Arnaud
    Vaillant-Beuchot, Loan
    Checler, Frederic
    Chami, Mounia
    M S-MEDECINE SCIENCES, 2021, 37 (10): : 843 - 847
  • [23] Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer's Disease
    Onukwufor, John O.
    Dirksen, Robert T.
    Wojtovich, Andrew P.
    ANTIOXIDANTS, 2022, 11 (04)
  • [24] Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?
    Bell, Simon M.
    Barnes, Katy
    De Marco, Matteo
    Shaw, Pamela J.
    Ferraiuolo, Laura
    Blackburn, Daniel J.
    Venneri, Annalena
    Mortiboys, Heather
    BIOMEDICINES, 2021, 9 (01) : 1 - 26
  • [25] Mitochondrial dysfunction and cellularmetabolic deficiency in Alzheimer's disease
    Xue-Mei Gu 1
    Neuroscience Bulletin, 2012, 28 (05) : 631 - 640
  • [26] Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
    Cai, Qian
    Tammineni, Prasad
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1087 - 1103
  • [27] The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease
    Cheng, Ying
    Bai, Feng
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [28] Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
    Moreira, Paula I.
    Carvalho, Cristina
    Zhu, Xiongwei
    Smith, Mark A.
    Perry, George
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01): : 2 - 10
  • [29] Mitochondrial Dysfunction: Cause and Consequence of Alzheimer's Disease
    Friedland-Leuner, Kristina
    Stockburgert, Carola
    Denzer, Isabel
    Eckert, Gunter P.
    Mueller, Walter E.
    MITOCHONDRION IN AGING AND DISEASE, 2014, 127 : 183 - 210
  • [30] Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
    Gunter P. Eckert
    Kathrin Renner
    Schamim H. Eckert
    Janett Eckmann
    Stephanie Hagl
    Reham M. Abdel-Kader
    Christopher Kurz
    Kristina Leuner
    Walter E. Muller
    Molecular Neurobiology, 2012, 46 : 136 - 150
12345